Goločorbin-Kon, Svetlana
Date issued
Type
Fulltext
Results 1-5 of 5 (Search time: 0.001 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 1-Jan-2015 | An advanced microencapsulated system: A platform for optimized oral delivery of antidiabetic drug-bile acid formulations | Mooranian A.; Negrulj R.; Mathavan S.; Martinez J.; Sciarretta J.; Chen-Tan N.; Mukkur T.; Momir Mikov ; Mladena Lalić-Popović ; Maja Stojančević; Svetlana Goločorbin-Kon ; Al-Salami H. |
| 2 | 1-Jan-2019 | Formulation buoyancy of nanoencapsulated gliclazide using primary, conjugated and deconjugated bile acids | Mathavan S.; Ionescu C.; Božica Kovačević; Momir Mikov ; Svetlana Goločorbin-Kon ; Mooranian A.; Dass C.; Al-Salami H. |
| 3 | 1-Jan-2008 | The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes | Momir Mikov ; Hani Al-Salami; Svetlana Goločorbin-Kon ; Ranko Škrbić; Aleksandar Rašković ; Paul J. Fawcett |
| 4 | 28-Jul-2014 | Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization study | Mooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Arfuso F.; Al-Salami H. |
| 5 | 1-Jan-2015 | Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment | Mooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Aruso F.; Al-Salami H. |